How to contact the center
Affiliated
HCP Center
Semmelweis University Budapest is a leading institution of higher education in Hungary and the Central European region within the area of medicine and health sciences. Its main commitment is based on the integrity of education, research and healing, which make Semmelweis University an internationally renowned centre of knowledge. A truly international community, programmes are offered in three languages (Hungarian, English, German), and international students account for nearly a third of the around 11,000 students studying at the University’s six faculties.
Research, development, and innovation comprise an important part of the University’s three-fold mission. The Department of Ophthalmology is the legal successor of the first Hungarian Department of Ophthalmology, which was founded in 1804. It has been operating in its present location since 1908. The Department provides a wide coverage of services for most ophthalmic conditions, including general ophthalmology, vitreoretinal service (conservative and surgical retina), ophthalmic oncology, pediatric ophthalmology, orthoptics, strabology and an outpatient clinic for inherited retinal disorders.
Research, development, and innovation comprise an important part of the University’s three-fold mission. The Department of Ophthalmology is the legal successor of the first Hungarian Department of Ophthalmology, which was founded in 1804. It has been operating in its present location since 1908. The Department provides a wide coverage of services for most ophthalmic conditions, including general ophthalmology, vitreoretinal service (conservative and surgical retina), ophthalmic oncology, pediatric ophthalmology, orthoptics, strabology and an outpatient clinic for inherited retinal disorders.
Contact
Department of Ophthalmology Semmelweis University, Budapest, Hungary
Mária u. 39
1085 Budapest
Hungary
Clinical trials
NCT03364153 - Active, Not recruiting
A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease
Interventional
NCT04435366 - Completed
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Interventional
NCT04276558 - Completed
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
Interventional
NCT05294978 - Recruiting, Active
Qualification for Cone-Optogenetics (EyeConic)
Observational